The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults

  1. Linda E. Lévesque, BScPhm, MSc;
  2. James M. Brophy, MD, PhD; and
  3. Bin Zhang, MSc
  1. From McGill University Health Centre, McGill University, Montréal, Québec, Canada.
    1. Figure. AMI = acute myocardial infarction; ICD-9 = International Classification of Diseases, Ninth Revision; NSAID = nonsteroidal anti-inflammatory drug.
      View larger version:
      Figure. AMI = acute myocardial infarction; ICD-9 = International Classification of Diseases, Ninth Revision; NSAID = nonsteroidal anti-inflammatory drug. Flow of study cohort.

    Responses to this article

      • James Brophy
      Ann Intern Med published online October 26, 2009
    • Considering cyclooxygenase-2 inhibitor in other point of view
      • Jeong A Kim and
      • Youn Seon Choi, Dokyung Yoon and Kyung Hwan Cho
      Ann Intern Med published online October 26, 2009
    • The Risk of Myocardial Infarction with Cyclooxygenase-2 Inhibitors
      • Michal R Pijak and
      • Igor Huzicka, Frantisek Gazdik
      Ann Intern Med published online October 26, 2009
    • A new hypothesis for the adverse effects of COX-2 inhibitors
      • Ken Shinmura and
      • Roberto Bolli, Institute of Molecular Cardiology, University of Lousiville
      Ann Intern Med published online October 26, 2009

    Summary for Patients

    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med April 5, 2005 vol. 142 no. 7 481-489
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
      1. Summary for Patients

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues